 The researchers report those who received the Ozempic class of drugs had a significantly lower risk of developing 10 out of 13 cancers studied. Those include kidney, pancreatic, esophageal, ovarian liver, and colorectal cancer. The risk of thyroid cancer and breast cancer in postmenopausal women was not reduced. Michael Toscano, CBS News.